Cytokinetics Inc. buy Needham & Company LLC
Start price
28.02.24
/
50%
€71.00
Target price
28.02.25
€99.73
Performance (%)
-17.61%
Price
29.04.24
€58.50
Summary
This prediction is currently active. The price of Cytokinetics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.61%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -6.400% | -6.400% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
09.04.24
09.04.24
€99.24
09.04.25
09.04.25
-13.97%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€73.50
27.12.23
27.12.23
€97.23
27.12.24
27.12.24
-20.41%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.40
20.10.23
20.10.23
€56.68
20.10.24
20.10.24
84.71%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
93.71%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24